Related Experiment Videos
Non-renal indications for peritoneal dialysis
1Department of Medicine, Ninewells Hospital & Medical School, Dundee, Scotland, U.K.
Insights
Peritoneal dialysis is rarely used for conditions beyond end-stage renal failure. While some cardiac patients benefit, its effectiveness for liver failure or pancreatitis remains unproven.
Area of Science:
- Nephrology
- Cardiology
- Hepatology
- Critical Care Medicine
Background:
- Peritoneal dialysis (PD) is a renal replacement therapy.
- Its application beyond end-stage renal disease (ESRD) is limited.
- Exploring alternative indications for PD is crucial for patient management.
Purpose of the Study:
- To review the current indications for peritoneal dialysis.
- To evaluate the efficacy of PD in non-renal conditions.
- To determine the role of PD in refractory cardiac failure, hepatic failure, and pancreatitis.
Main Methods:
- Literature review of studies on peritoneal dialysis.
- Analysis of case reports and clinical trials.
- Assessment of outcomes in patients treated with PD for various conditions.
Main Results:
- Continuous ambulatory peritoneal dialysis (CAPD) may benefit patients with refractory congestive cardiac failure awaiting transplantation.
- Evidence does not support improved prognosis for fulminant hepatic failure or severe acute pancreatitis with PD.
- Isolated cases suggest PD's utility in hypothermia, hyperthermia, dialysis-associated ascites, and drug poisonings.
Conclusions:
- Renal failure remains the primary indication for initiating peritoneal dialysis.
- PD offers potential benefits in specific cardiac conditions but lacks proven efficacy in severe liver or pancreatic disease.
- Further research is needed to establish PD's role in non-traditional indications.
Abstract:
Peritoneal dialysis is rarely indicated for conditions other than end-stage renal failure. Patients with refractory congestive cardiac failure, who are awaiting cardiac transplantation or have potentially reversible cardiac disease, appear to benefit from CAPD. The prognosis of patients with fulminant hepatic failure or severe acute pancreatitis has not yet been shown to improve with the addition of peritoneal dialysis to standard supportive treatment. Isolated reports have suggested that patients with hypothermia, hyperthermia, dialysis-associated ascites and drug poisonings may be treated successfully with peritoneal dialysis. The above indications are encountered infrequently and renal failure remains the only major indication for commencing patients on peritoneal dialysis.